Oragenics Inc entered into an Asset Purchase Agreement with Odyssey Health Inc to purchase certain assets and liabilities related to a segment of Odyssey's business focused on developing medical products that treat brain-related illnesses and diseases in exchange for $1,000,000 in cash and 8,000,000 shares of convertible Series F Preferred Stock.